TEVA logo

TEVA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-102.89%
TEVA Quarterly EBITDA YoY % (53.07% → -102.89%)
High-resolution chart · PNG

TEVA ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares EBITDA Growth — Quarterly
Period endingEBITDA Growth
-102.8919%
-7.9748%
-45.611%
433.3333%
167.0732%
1,632.7273%
-23.4015%
-66.9856%
-74.6392%
-93.1507%
358.8737%
-15.1556%
-3.8652%
317.6152%
-353.6797%
-28.8739%
12.3608%
-145.5556%
-79.3196%
126.2307%
62.0939%
37.2881%
0.0896%
-1,293.0723%
385.567%
2.253%
140.9091%
-70.3041%
-141.7204%
-71.6043%
78.3148%
-20.9335%
109.0064%
47.7818%
-12,355.4455%
5.3651%
-869.4486%
-6.4626%
-106.98%
-17.6687%
-59.284%
35.6089%
11.4792%
10.6585%
26.8668%
-21.2209%
42.4808%
2.935%
798.3871%
2.381%
31.6474%
306.5341%
-113.3717%
-7.1182%
-26.5393%
-72.5429%
472.9223%
27.714%
-8.0078%
-11.4029%
-128.5168%
5.9869%
132.7273%
43.6941%
36.3921%
50.7757%
162.5%
29.601%
26.1842%
-11.9255%
-187.8901%
1.5686%
-0.9126%
38.0789%
52.0501%
-8.2404%
-4.7323%
48.3461%
27.6008%
167.0404%
160.8879%
1.7081%
23.0918%
-1.7312%
3.8708%
-54.5839%
9.3577%
61.1872%
5.392%
374.512%
67.9628%
62.0888%
152.5986%
65.7116%
43.9042%
22.8283%
28.4974%
37.1287%
-27.8842%
33.0288%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.